Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 relative bioavailability study assessing AL001 for dementia related to Alzheimer's disease

Trial Profile

A Phase 1 relative bioavailability study assessing AL001 for dementia related to Alzheimer's disease

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 04 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lithium cocrystal Alzamend Neuro (Primary) ; Lithium
  • Indications Alzheimer's disease; Cognition disorders; Dementia
  • Focus First in man; Pharmacokinetics

Most Recent Events

  • 28 Apr 2022 Status changed from recruiting to completed according to BitNile Holdings media release.
  • 28 Apr 2022 According to an Alzamend Neuro media release, Alzamend Neuro announces Dollar 4 million additional investment from Digital Power lending upon completion of this trial
  • 28 Mar 2022 According to an Alzamend Neuro media release, Alzamend announced that it has received the full data set from this Phase 1 clinical trial for AL001, full data demonstrate AL001 in plasma is bioequivalent to the marketed lithium carbonate product

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top